Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
23.04.25
/
50%
€103.95
Target price
23.04.26
€172.63
Performance (%)
43.65%
Price
16:36
€149.32
This prediction will end soon
Summary
This prediction is currently active. The BUY prediction by The_Goldman_Sachs_Gr for Biogen Inc. has seen massive gains of 43.65%. This prediction currently runs until 23.04.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -1.282% | -1.282% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $219.00 to $197.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat